The COL5A1 gene helps your body make type V collagen, a protein that supports the strength and structure of skin, tendons, ligaments, and other connective tissues. The protein made by this gene helps your cells organize collagen so tissues can stretch and recover in a controlled way. If the COL5A1 gene does not work properly, connective tissue may be looser or more fragile, which can lead to very flexible joints, stretchy skin, easy bruising, and in some people classic Ehlers-Danlos syndrome.
What is a gene?
Genes are stretches of DNA that give cells instructions they can use to make molecules or direct activities in the body. Some genes carry the code for proteins, which do much of the work inside cells. Other genes are used mainly to regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
COL5A1Gene function
What if the gene works
The COL5A1 gene helps make type V collagen, a protein that supports skin, tendons, ligaments, and other connective tissues. It helps control how collagen fibers form, giving tissues strength and flexibility.
Risk
What if the gene does not work
Variants in the COL5A1 gene often cause classical Ehlers-Danlos syndrome, with stretchy skin, unusual scarring, and flexible joints. Milder or more severe variants can influence when features appear and how strongly connective tissues are affected.
Treatment
What does that mean for your treatment
No COL5A1-specific treatment or drug selection is currently established. Care for people with pathogenic variants in the COL5A1 gene is symptom-based, such as joint protection, pain management, and monitoring for complications, rather than tailored to the gene change itself. The COL5A1 gene is also being studied as a tissue remodeling marker in cancer and fibrosis research, but this does not guide routine treatment.
Conditions associated with COL5A1
Gene function
What if the gene works
Your cells rely on the COL5A1 gene to build part of type V collagen, one of the proteins that gives connective tissue its structure. This protein helps organize collagen fibers so tissues can stretch and support daily movement. In day to day life, that supports the steady feel and flexibility of tissues such as skin, tendons, and ligaments.
The COL5A1 gene provides instructions for one piece of type V collagen, a connective tissue protein. Cells combine this piece with others and place the finished collagen into the material that surrounds cells.
Type V collagen helps start collagen fiber formation and guides fiber thickness. This keeps connective tissue fibers more evenly arranged, especially alongside the more common type I collagen.
Well-organized collagen helps skin, tendons, ligaments, and tissue around joints handle everyday pulling and bending. This is part of how the COL5A1 gene supports collagen in skin and joints and helps tissues stay resilient.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
COL5A1 gene variants linked to classical Ehlers-Danlos syndrome often either reduce how much protein a cell makes or change the protein’s shape, so collagen fibers are built less reliably. Some variants are milder and cause only partial loss of function, while more disruptive variants can sharply lower protein levels or let an altered protein interfere with fiber assembly. That range in effect can influence how early features appear and how marked they are.
How variants are linked to conditions
Pathogenic variants in the COL5A1 gene cause classic Ehlers-Danlos syndrome, a condition linked with very flexible joints, stretchy skin, easy bruising, and widened scars. In clinical genetics, the COL5A1 gene and Ehlers-Danlos syndrome are closely linked, especially the classic type. Some common COL5A1 variants have also been associated with tendon or ligament injury risk in research studies, but these findings do not diagnose a condition or predict injury for one person.
A variant is not necessarily a diagnosis
Genetic variants are a common, normal feature of human biology. Most do not directly affect health and instead reflect natural variation among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well studied variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For COL5A1, risk is mainly shaped by whether a disease-causing gene change is inherited in the family. There is not yet broadly confirmed evidence that lifestyle or everyday exposures clearly increase or reduce the chance of having a COL5A1-related condition, although symptoms and complications can vary from person to person.
Inheritance of COL5A1 variants
Most disease-causing variants in the COL5A1 gene follow an autosomal dominant inheritance pattern, which is the usual COL5A1 inheritance pattern linked to classic Ehlers-Danlos syndrome. This means a person only needs one altered copy of the gene to have the condition, and each child of an affected parent has a 50% chance of inheriting that variant. Some people have a new, de novo variant, meaning it arose for the first time in them rather than being passed down from either parent. Because COL5A1 is not on a sex chromosome, it can be passed from mothers or fathers to sons or daughters.
What does my COL5A1 result mean for my family?
For many living with a disease-causing change in the COL5A1 gene, close relatives such as a parent, brother, sister, or child may also carry the same change and could have similar features, even if symptoms are milder. This gene is most often linked to a dominant pattern, so family members sometimes choose to learn whether the result runs in the family. Some cases happen for the first time in one person, so a parent does not always have the same gene change.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the COL5A1 gene, COL5A1 genetic testing reads DNA from a blood sample, saliva, or a cheek swab. It can identify a known harmful variant, confirm a suspected inherited condition, or show that no relevant variant was found.
When should I consider getting a genetic test?
Consider testing for changes in the COL5A1 gene if you or your child has signs of classical Ehlers-Danlos syndrome, such as unusually stretchy skin, joints that move too far, easy bruising, or scars that widen over time. It can also be helpful when these features run in the family or when a doctor wants to confirm the cause.
A genetic result is only one part of your health story
A genetic finding can offer useful insight, but what it can tell you depends on the condition and on the kind of variant involved. How the body functions over time is shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment and have different results because their bodies may break down, transport, or respond to a drug in different ways. This is common and can influence how well a medicine works or how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way a person responds to medications. It studies connections between genes and drugs to better explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support treatment decisions that are more informed and more individualized. More on this topic is available in the LearnHub.
Drugs influenced by the COL5A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. If you have concerns about side effects, starting a new medicine, or how your health condition may affect treatment, talk with your doctor or pharmacist.
History
Throughout history, people have described unusually stretchy skin and flexible joints, features now recognized in many people with changes in the COL5A1 gene. Early medical reports grouped these findings under what became known as Ehlers-Danlos syndrome, long before the specific gene was identified. In the late 20th century, researchers linked classical Ehlers-Danlos syndrome to changes in collagen genes, including the COL5A1 gene. Building on this early work, scientists uncovered more about the COL5A1 gene as genetic testing improved and families could be studied in greater detail. This helped separate classical forms of Ehlers-Danlos syndrome from other connective tissue conditions. Today, COL5A1 is an established part of the history of inherited connective tissue research.